Indazole derivatives as kinase inhibitors for the treatment of cancer
US8114865B2 · kind B2 · utility
17Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2007 |
| Grant date | Feb 14, 2012 |
| Priority date | — |
| Expiry date | Aug 28, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Substituted indazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a dysregulated protein kinase activity, like cancer formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.